Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-25 @ 8:06 PM
Study NCT ID:
NCT06176235
Status:
WITHDRAWN
Last Update Posted:
2025-08-11
First Post:
2023-12-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
Sponsor:
Peking University People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-09
First Submit QC Date:
None
Study First Post Date:
2023-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-05
Last Update Post Date:
2025-08-11
Last Update Post Date Type:
ACTUAL